Product News: ELITechGroup Molecular Diagnostics Announces a Multiplex Assay for the Detection of Three Major STI Pathogens

13 Jun 2017

ELITechGroup Molecular Diagnostics announces the CE-IVD marking of the STI ELITe MGB® Panel: a multiplex assay for the detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Mycoplasma genitalium (MG), three major bacteria involved in Sexually Transmitted Infections. STIs are a global burden with more than 1 million infections acquired every day worldwide. Accurate and specific detection is important to reduce transmission and complications.

In combination with the ELITe InGenius system, the STI ELITe MGB® Panel is the first CE-IVD triplex assay available with a sample-to-result solution to simultaneously detect and differentiate in one single reaction Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium. Patient samples can be directly loaded into the system, which automatically performs all the steps of molecular diagnostics from extraction to result interpretation with minimal hands-on time. The clinical study has demonstrated excellent performance: respectively 96.4%, 100%, and 100% diagnostic sensitivity and 100%, 98.4% and C. trachomatis, N. gonorrhoeae and M. genitalium.

“STI ELITe MGB® Panel is the 22nd CE-IVD assay pf ELITe InGenius menu and the first one intended to diagnose sexually transmitted infections. This launch is thus an important milestone in our strategy to offer the broadest infectious disease menu on any sample-to-result system and cover the main clinical applications of molecular diagnostics” commented C. Gauer, CEO of ELITechGroup.

Recently identified, M. genitalium is highly prevalent in the general population, and share similar symptoms with C. trachomatis and N. gonorrhoeae, but their specific antibiotic treatments are not fully efficient to cure M. genitalium and generate antibiotics resistance strains. Co-detection of Mycoplasma genitalium, along with Chlamydia trachomatis, Neisseria gonorrhoeae improved the efficiency of STI diagnosis and patient management.

ELITe InGenius offer a unique menu with quantitative and qualitative assays for transplant pathogen monitoring, healthcare associated infections, respiratory infections, meningitis, sexually transmitted infections, and the testing of coagulation factors.